USPTO serial 99435673
TRUPATH
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- LINERO GUARDA, GERARDO INAKI
- Law office
- TMO LAW OFFICE 127
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TRUPATH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Agents, reagents, assays, enzymes, nucleotides, and buffers for scientific and research use; Agents, reagents, assays, enzymes, nucleotides, and buffers for scientific and research use, in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for research and scientific purposes; Kits containing reagents, enzymes, assays, buffers and flow cells for non-medical purposes; Kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, all for research, scientific, and industrial purposes; Chemical agents and reagents used in scientific and research genetic sequencing to identify and expand scope of sequenced material | ACTIVE | — |
| 005 | Agents, reagents, assays, enzymes, nucleotides, and buffers for medical, dental, and veterinary use in the fields of genetic sequencing, genotyping, genomics, genetic testing, and nucleic acid sequencing; Chemical reagents for sequencing DNA, RNA, and nucleic acids, for medical purposes; Kits containing reagents, agents, enzymes, assays, buffers and flow cells for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Kits comprising chemical reagents, DNA sequences, nucleic acids, enzymes, nucleotides, and flow cell cartridges, for medical purposes in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Chemical agents and reagents for genetic sequencing to identify and expand scope of sequenced material for medical purposes in the field of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing | ACTIVE | — |
| 009 | Downloadable software for storing, comparing, displaying, analyzing, managing, compressing, decompressing, creating, synchronizing, securing and archiving of genetic sequencing data and files and for file management and for computer file management, all of the foregoing in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Downloadable software for scientific analysis of genetic sequences; Downloadable software for creating a database of genetic sequences for scientific, research and medical analysis; Downloadable software for storing, organizing and creating a searchable library of genetic data for use in sequence detection; Downloadable software for database management, for creating searchable databases of genetic sequencing information and data, and for storage of electronic genetic sequencing data; Downloadable databases in the field of genetics; Downloadable electronic reports featuring data summaries and analysis in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Downloadable software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, genomics, and genetics; Downloadable software for processing, visualizing, storing, sharing, and manipulating next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genomics, genetic testing, and genetics; flow cell cartridges for genetic sequencing; flow cell analyzers for genetic sequencing; none of the foregoing in the fields of smell, taste, or ectopic and chemosensory receptors | ACTIVE | — |
| 041 | Online non-downloadable publications in the nature of electronic reports featuring data and analysis in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, genomics, and genetics; Software as a service (SAAS) services featuring software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, genomics, and genetics; Providing scientific analysis of genomic data for scientific and research purposes; Software as a service (SAAS) services featuring software for storing, organizing and creating a searchable library of genetic data for use in sequence detection; Software as a service (SAAS) services featuring software that provide non-downloadable databases in the field of genetics; Software as a service (SAAS) services featuring software to store, share, and analyze, DNA, RNA and genetic data; Providing scientific research information in the form of online non-downloadable electronic reports featuring data and analysis in the fields of genetic sequencing, genotyping, metagenomics, genetic testing, and nucleic acid sequencing; Design and development of databases for collecting, storing, analyzing, and reporting genetic information; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; Providing online non-downloadable software for use in streamlining genomics workflow | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 22, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2026 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Apr 20, 2026 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Feb 27, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 9, 2025 | NWAP | NEW APPLICATION ENTERED | — |